Alkermes plc ALKS

Healthcare Biotechnology

Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.

NDAQ:ALKS - Post by User

Alkermes plc

Bullboard Posts

Post by stocksinnewson Jul 19, 2005 11:57am

394 Views

Post# 9294974

ALKS --- Fresh July High ---

ALKS --- Fresh July High --- ALKS the stock shows strength today as it pushed higher above yesterday's high to record fresh July high of(14.83). But you should take caution with this stock as the RSI(14) moves to overbought area suggesting for possible reversal. and more at: WWW.stocksinnews.com

Bullboard Posts

One of the strongest contenders to lead Canada’s cannabis market